Mesoblast (MESO) Total Liabilities (2014 - 2026)

Mesoblast has reported Total Liabilities for 11 years, with the latest figure at $207.6 million in Q4 2025.

• Quarterly Total Liabilities rose 8.11% year-over-year to $207.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $207.6 million (up 8.11% YoY) and the FY2025 annual result came in at $187.2 million, down 0.82% from the prior year.
• Total Liabilities grew to $207.6 million in Q4 2025 per MESO's latest filing, from $187.2 million in the prior quarter.
• Over five years, Total Liabilities peaked at $207.6 million in Q4 2025 and troughed at $161.6 million in Q4 2023.
• A 5-year average of $172.8 million and a median of $167.6 million in 2023 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2021 and 2024: Total Liabilities decreased 11.37% in 2021, then grew 18.88% in 2024.
• Over 5 years, Total Liabilities stood at $168.9 million in 2021, then decreased by 0.52% to $168.1 million in 2022, then slipped by 3.87% to $161.6 million in 2023, then advanced by 18.88% to $192.1 million in 2024, then gained by 8.11% to $207.6 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $207.6 million, $187.2 million, and $192.1 million for Q4 2025, Q2 2025, and Q4 2024 respectively.